img

Global Paediatric Vaccine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Paediatric Vaccine Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Paediatric Vaccine Market
Global Paediatric Vaccine market is expected to reach to US$ 22580 million in 2023, with a positive growth of %, compared with US$ 21400 million in 2022. Backed with the increasing demand from downstream industries, Paediatric Vaccine industry is evaluated to reach US$ 31130 million in 2033. The CAGR will be 5.5% during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Paediatric Vaccine market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Paediatric Vaccine market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


GlaxoSmithCline
Merck
Sanofi
Bristol-Myers Squibb
Abbott Laboratories
Eli Lilly
Pfizer
F. Hoffmann-La Roche
Novo Nordisk
Segment by Type
Pneumococcal
Varicella
Combinations
Poliovirus
Hepatitis
MMR
Pediatric Hormones
HIB
Allergy and Respiratory vaccines
Other Pediatric vaccines

Segment by Application


Age (0-3)
Age (3-12)
Age Above 12
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Paediatric Vaccine introduction, etc. Paediatric Vaccine Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Paediatric Vaccine
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Paediatric Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Pneumococcal
1.2.3 Varicella
1.2.4 Combinations
1.2.5 Poliovirus
1.2.6 Hepatitis
1.2.7 MMR
1.2.8 Pediatric Hormones
1.2.9 HIB
1.2.10 Allergy and Respiratory vaccines
1.2.11 Other Pediatric vaccines
1.3 Market by Application
1.3.1 Global Paediatric Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Age (0-3)
1.3.3 Age (3-12)
1.3.4 Age Above 12
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Paediatric Vaccine Market Perspective (2018-2033)
2.2 Global Paediatric Vaccine Growth Trends by Region
2.2.1 Paediatric Vaccine Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Paediatric Vaccine Historic Market Size by Region (2018-2023)
2.2.3 Paediatric Vaccine Forecasted Market Size by Region (2024-2033)
2.3 Paediatric Vaccine Market Dynamics
2.3.1 Paediatric Vaccine Industry Trends
2.3.2 Paediatric Vaccine Market Drivers
2.3.3 Paediatric Vaccine Market Challenges
2.3.4 Paediatric Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Paediatric Vaccine by Players
3.1.1 Global Paediatric Vaccine Revenue by Players (2018-2023)
3.1.2 Global Paediatric Vaccine Revenue Market Share by Players (2018-2023)
3.2 Global Paediatric Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Paediatric Vaccine, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Paediatric Vaccine Market Concentration Ratio
3.4.1 Global Paediatric Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Paediatric Vaccine Revenue in 2022
3.5 Global Key Players of Paediatric Vaccine Head office and Area Served
3.6 Global Key Players of Paediatric Vaccine, Product and Application
3.7 Global Key Players of Paediatric Vaccine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Paediatric Vaccine Breakdown Data by Type
4.1 Global Paediatric Vaccine Historic Market Size by Type (2018-2023)
4.2 Global Paediatric Vaccine Forecasted Market Size by Type (2024-2033)
5 Paediatric Vaccine Breakdown Data by Application
5.1 Global Paediatric Vaccine Historic Market Size by Application (2018-2023)
5.2 Global Paediatric Vaccine Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Paediatric Vaccine Market Size (2018-2033)
6.2 North America Paediatric Vaccine Market Size by Type
6.2.1 North America Paediatric Vaccine Market Size by Type (2018-2023)
6.2.2 North America Paediatric Vaccine Market Size by Type (2024-2033)
6.2.3 North America Paediatric Vaccine Market Share by Type (2018-2033)
6.3 North America Paediatric Vaccine Market Size by Application
6.3.1 North America Paediatric Vaccine Market Size by Application (2018-2023)
6.3.2 North America Paediatric Vaccine Market Size by Application (2024-2033)
6.3.3 North America Paediatric Vaccine Market Share by Application (2018-2033)
6.4 North America Paediatric Vaccine Market Size by Country
6.4.1 North America Paediatric Vaccine Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Paediatric Vaccine Market Size by Country (2018-2023)
6.4.3 North America Paediatric Vaccine Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Paediatric Vaccine Market Size (2018-2033)
7.2 Europe Paediatric Vaccine Market Size by Type
7.2.1 Europe Paediatric Vaccine Market Size by Type (2018-2023)
7.2.2 Europe Paediatric Vaccine Market Size by Type (2024-2033)
7.2.3 Europe Paediatric Vaccine Market Share by Type (2018-2033)
7.3 Europe Paediatric Vaccine Market Size by Application
7.3.1 Europe Paediatric Vaccine Market Size by Application (2018-2023)
7.3.2 Europe Paediatric Vaccine Market Size by Application (2024-2033)
7.3.3 Europe Paediatric Vaccine Market Share by Application (2018-2033)
7.4 Europe Paediatric Vaccine Market Size by Country
7.4.1 Europe Paediatric Vaccine Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Paediatric Vaccine Market Size by Country (2018-2023)
7.4.3 Europe Paediatric Vaccine Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Paediatric Vaccine Market Size (2018-2033)
8.2 China Paediatric Vaccine Market Size by Type
8.2.1 China Paediatric Vaccine Market Size by Type (2018-2023)
8.2.2 China Paediatric Vaccine Market Size by Type (2024-2033)
8.2.3 China Paediatric Vaccine Market Share by Type (2018-2033)
8.3 China Paediatric Vaccine Market Size by Application
8.3.1 China Paediatric Vaccine Market Size by Application (2018-2023)
8.3.2 China Paediatric Vaccine Market Size by Application (2024-2033)
8.3.3 China Paediatric Vaccine Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Paediatric Vaccine Market Size (2018-2033)
9.2 Asia Paediatric Vaccine Market Size by Type
9.2.1 Asia Paediatric Vaccine Market Size by Type (2018-2023)
9.2.2 Asia Paediatric Vaccine Market Size by Type (2024-2033)
9.2.3 Asia Paediatric Vaccine Market Share by Type (2018-2033)
9.3 Asia Paediatric Vaccine Market Size by Application
9.3.1 Asia Paediatric Vaccine Market Size by Application (2018-2023)
9.3.2 Asia Paediatric Vaccine Market Size by Application (2024-2033)
9.3.3 Asia Paediatric Vaccine Market Share by Application (2018-2033)
9.4 Asia Paediatric Vaccine Market Size by Region
9.4.1 Asia Paediatric Vaccine Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Paediatric Vaccine Market Size by Region (2018-2023)
9.4.3 Asia Paediatric Vaccine Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Paediatric Vaccine Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Type
10.2.1 Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Paediatric Vaccine Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Application
10.3.1 Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Paediatric Vaccine Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Country
10.4.1 Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GlaxoSmithCline
11.1.1 GlaxoSmithCline Company Details
11.1.2 GlaxoSmithCline Business Overview
11.1.3 GlaxoSmithCline Paediatric Vaccine Introduction
11.1.4 GlaxoSmithCline Revenue in Paediatric Vaccine Business (2018-2023)
11.1.5 GlaxoSmithCline Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Paediatric Vaccine Introduction
11.2.4 Merck Revenue in Paediatric Vaccine Business (2018-2023)
11.2.5 Merck Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Paediatric Vaccine Introduction
11.3.4 Sanofi Revenue in Paediatric Vaccine Business (2018-2023)
11.3.5 Sanofi Recent Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Paediatric Vaccine Introduction
11.4.4 Bristol-Myers Squibb Revenue in Paediatric Vaccine Business (2018-2023)
11.4.5 Bristol-Myers Squibb Recent Developments
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Paediatric Vaccine Introduction
11.5.4 Abbott Laboratories Revenue in Paediatric Vaccine Business (2018-2023)
11.5.5 Abbott Laboratories Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Paediatric Vaccine Introduction
11.6.4 Eli Lilly Revenue in Paediatric Vaccine Business (2018-2023)
11.6.5 Eli Lilly Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Paediatric Vaccine Introduction
11.7.4 Pfizer Revenue in Paediatric Vaccine Business (2018-2023)
11.7.5 Pfizer Recent Developments
11.8 F. Hoffmann-La Roche
11.8.1 F. Hoffmann-La Roche Company Details
11.8.2 F. Hoffmann-La Roche Business Overview
11.8.3 F. Hoffmann-La Roche Paediatric Vaccine Introduction
11.8.4 F. Hoffmann-La Roche Revenue in Paediatric Vaccine Business (2018-2023)
11.8.5 F. Hoffmann-La Roche Recent Developments
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Details
11.9.2 Novo Nordisk Business Overview
11.9.3 Novo Nordisk Paediatric Vaccine Introduction
11.9.4 Novo Nordisk Revenue in Paediatric Vaccine Business (2018-2023)
11.9.5 Novo Nordisk Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Paediatric Vaccine Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Pneumococcal
Table 3. Key Players of Varicella
Table 4. Key Players of Combinations
Table 5. Key Players of Poliovirus
Table 6. Key Players of Hepatitis
Table 7. Key Players of MMR
Table 8. Key Players of Pediatric Hormones
Table 9. Key Players of HIB
Table 10. Key Players of Allergy and Respiratory vaccines
Table 11. Key Players of Other Pediatric vaccines
Table 12. Global Paediatric Vaccine Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 13. Global Paediatric Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 14. Global Paediatric Vaccine Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Paediatric Vaccine Market Share by Region (2018-2023)
Table 16. Global Paediatric Vaccine Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 17. Global Paediatric Vaccine Market Share by Region (2024-2033)
Table 18. Paediatric Vaccine Market Trends
Table 19. Paediatric Vaccine Market Drivers
Table 20. Paediatric Vaccine Market Challenges
Table 21. Paediatric Vaccine Market Restraints
Table 22. Global Paediatric Vaccine Revenue by Players (2018-2023) & (US$ Million)
Table 23. Global Paediatric Vaccine Revenue Share by Players (2018-2023)
Table 24. Global Top Paediatric Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paediatric Vaccine as of 2022)
Table 25. Global Paediatric Vaccine Industry Ranking 2021 VS 2022 VS 2023
Table 26. Global 5 Largest Players Market Share by Paediatric Vaccine Revenue (CR5 and HHI) & (2018-2023)
Table 27. Global Key Players of Paediatric Vaccine, Headquarters and Area Served
Table 28. Global Key Players of Paediatric Vaccine, Product and Application
Table 29. Global Key Players of Paediatric Vaccine, Product and Application
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Paediatric Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 32. Global Paediatric Vaccine Revenue Market Share by Type (2018-2023)
Table 33. Global Paediatric Vaccine Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 34. Global Paediatric Vaccine Revenue Market Share by Type (2024-2033)
Table 35. Global Paediatric Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 36. Global Paediatric Vaccine Revenue Share by Application (2018-2023)
Table 37. Global Paediatric Vaccine Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 38. Global Paediatric Vaccine Revenue Share by Application (2024-2033)
Table 39. North America Paediatric Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 40. North America Paediatric Vaccine Market Size by Type (2024-2033) & (US$ Million)
Table 41. North America Paediatric Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 42. North America Paediatric Vaccine Market Size by Application (2024-2033) & (US$ Million)
Table 43. North America Paediatric Vaccine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. North America Paediatric Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 45. North America Paediatric Vaccine Market Size by Country (2024-2033) & (US$ Million)
Table 46. Europe Paediatric Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 47. Europe Paediatric Vaccine Market Size by Type (2024-2033) & (US$ Million)
Table 48. Europe Paediatric Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 49. Europe Paediatric Vaccine Market Size by Application (2024-2033) & (US$ Million)
Table 50. Europe Paediatric Vaccine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 51. Europe Paediatric Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 52. Europe Paediatric Vaccine Market Size by Country (2024-2033) & (US$ Million)
Table 53. China Paediatric Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 54. China Paediatric Vaccine Market Size by Type (2024-2033) & (US$ Million)
Table 55. China Paediatric Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 56. China Paediatric Vaccine Market Size by Application (2024-2033) & (US$ Million)
Table 57. Asia Paediatric Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 58. Asia Paediatric Vaccine Market Size by Type (2024-2033) & (US$ Million)
Table 59. Asia Paediatric Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 60. Asia Paediatric Vaccine Market Size by Application (2024-2033) & (US$ Million)
Table 61. Asia Paediatric Vaccine Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 62. Asia Paediatric Vaccine Market Size by Region (2018-2023) & (US$ Million)
Table 63. Asia Paediatric Vaccine Market Size by Region (2024-2033) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Type (2024-2033) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Application (2024-2033) & (US$ Million)
Table 68. Middle East, Africa, and Latin America Paediatric Vaccine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 69. Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 70. Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Country (2024-2033) & (US$ Million)
Table 71. GlaxoSmithCline Company Details
Table 72. GlaxoSmithCline Business Overview
Table 73. GlaxoSmithCline Paediatric Vaccine Product
Table 74. GlaxoSmithCline Revenue in Paediatric Vaccine Business (2018-2023) & (US$ Million)
Table 75. GlaxoSmithCline Recent Developments
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Paediatric Vaccine Product
Table 79. Merck Revenue in Paediatric Vaccine Business (2018-2023) & (US$ Million)
Table 80. Merck Recent Developments
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi Paediatric Vaccine Product
Table 84. Sanofi Revenue in Paediatric Vaccine Business (2018-2023) & (US$ Million)
Table 85. Sanofi Recent Developments
Table 86. Bristol-Myers Squibb Company Details
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb Paediatric Vaccine Product
Table 89. Bristol-Myers Squibb Revenue in Paediatric Vaccine Business (2018-2023) & (US$ Million)
Table 90. Bristol-Myers Squibb Recent Developments
Table 91. Abbott Laboratories Company Details
Table 92. Abbott Laboratories Business Overview
Table 93. Abbott Laboratories Paediatric Vaccine Product
Table 94. Abbott Laboratories Revenue in Paediatric Vaccine Business (2018-2023) & (US$ Million)
Table 95. Abbott Laboratories Recent Developments
Table 96. Eli Lilly Company Details
Table 97. Eli Lilly Business Overview
Table 98. Eli Lilly Paediatric Vaccine Product
Table 99. Eli Lilly Revenue in Paediatric Vaccine Business (2018-2023) & (US$ Million)
Table 100. Eli Lilly Recent Developments
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Paediatric Vaccine Product
Table 104. Pfizer Revenue in Paediatric Vaccine Business (2018-2023) & (US$ Million)
Table 105. Pfizer Recent Developments
Table 106. F. Hoffmann-La Roche Company Details
Table 107. F. Hoffmann-La Roche Business Overview
Table 108. F. Hoffmann-La Roche Paediatric Vaccine Product
Table 109. F. Hoffmann-La Roche Revenue in Paediatric Vaccine Business (2018-2023) & (US$ Million)
Table 110. F. Hoffmann-La Roche Recent Developments
Table 111. Novo Nordisk Company Details
Table 112. Novo Nordisk Business Overview
Table 113. Novo Nordisk Paediatric Vaccine Product
Table 114. Novo Nordisk Revenue in Paediatric Vaccine Business (2018-2023) & (US$ Million)
Table 115. Novo Nordisk Recent Developments
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Paediatric Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Paediatric Vaccine Market Share by Type: 2022 VS 2033
Figure 3. Pneumococcal Features
Figure 4. Varicella Features
Figure 5. Combinations Features
Figure 6. Poliovirus Features
Figure 7. Hepatitis Features
Figure 8. MMR Features
Figure 9. Pediatric Hormones Features
Figure 10. HIB Features
Figure 11. Allergy and Respiratory vaccines Features
Figure 12. Other Pediatric vaccines Features
Figure 13. Global Paediatric Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 14. Global Paediatric Vaccine Market Share by Application: 2022 VS 2033
Figure 15. Age (0-3) Case Studies
Figure 16. Age (3-12) Case Studies
Figure 17. Age Above 12 Case Studies
Figure 18. Paediatric Vaccine Report Years Considered
Figure 19. Global Paediatric Vaccine Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 20. Global Paediatric Vaccine Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 21. Global Paediatric Vaccine Market Share by Region: 2022 VS 2033
Figure 22. Global Paediatric Vaccine Market Share by Players in 2022
Figure 23. Global Top Paediatric Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paediatric Vaccine as of 2022)
Figure 24. The Top 10 and 5 Players Market Share by Paediatric Vaccine Revenue in 2022
Figure 25. North America Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. North America Paediatric Vaccine Market Share by Type (2018-2033)
Figure 27. North America Paediatric Vaccine Market Share by Application (2018-2033)
Figure 28. North America Paediatric Vaccine Market Share by Country (2018-2033)
Figure 29. United States Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Canada Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Europe Paediatric Vaccine Market Size YoY (2018-2033) & (US$ Million)
Figure 32. Europe Paediatric Vaccine Market Share by Type (2018-2033)
Figure 33. Europe Paediatric Vaccine Market Share by Application (2018-2033)
Figure 34. Europe Paediatric Vaccine Market Share by Country (2018-2033)
Figure 35. Germany Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. France Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. U.K. Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Italy Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Russia Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Nordic Countries Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. China Paediatric Vaccine Market Size YoY (2018-2033) & (US$ Million)
Figure 42. China Paediatric Vaccine Market Share by Type (2018-2033)
Figure 43. China Paediatric Vaccine Market Share by Application (2018-2033)
Figure 44. Asia Paediatric Vaccine Market Size YoY (2018-2033) & (US$ Million)
Figure 45. Asia Paediatric Vaccine Market Share by Type (2018-2033)
Figure 46. Asia Paediatric Vaccine Market Share by Application (2018-2033)
Figure 47. Asia Paediatric Vaccine Market Share by Region (2018-2033)
Figure 48. Japan Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. South Korea Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. China Taiwan Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Southeast Asia Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. India Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Australia Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Middle East, Africa, and Latin America Paediatric Vaccine Market Size YoY (2018-2033) & (US$ Million)
Figure 55. Middle East, Africa, and Latin America Paediatric Vaccine Market Share by Type (2018-2033)
Figure 56. Middle East, Africa, and Latin America Paediatric Vaccine Market Share by Application (2018-2033)
Figure 57. Middle East, Africa, and Latin America Paediatric Vaccine Market Share by Country (2018-2033)
Figure 58. Brazil Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Mexico Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. Turkey Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 61. Saudi Arabia Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 62. Israel Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 63. GCC Countries Paediatric Vaccine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 64. GlaxoSmithCline Revenue Growth Rate in Paediatric Vaccine Business (2018-2023)
Figure 65. Merck Revenue Growth Rate in Paediatric Vaccine Business (2018-2023)
Figure 66. Sanofi Revenue Growth Rate in Paediatric Vaccine Business (2018-2023)
Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Paediatric Vaccine Business (2018-2023)
Figure 68. Abbott Laboratories Revenue Growth Rate in Paediatric Vaccine Business (2018-2023)
Figure 69. Eli Lilly Revenue Growth Rate in Paediatric Vaccine Business (2018-2023)
Figure 70. Pfizer Revenue Growth Rate in Paediatric Vaccine Business (2018-2023)
Figure 71. F. Hoffmann-La Roche Revenue Growth Rate in Paediatric Vaccine Business (2018-2023)
Figure 72. Novo Nordisk Revenue Growth Rate in Paediatric Vaccine Business (2018-2023)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries